FOLIC ACID by Eli Lilly and Company is clinical pharmacology folic acid acts on megaloblastic bone marrow to produce a normoblastic marrow. First approved in 1947.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
Folic acid is an oral small-molecule B-vitamin supplement approved in 1947 for prevention and treatment of folate deficiency. It is indicated across a broad spectrum of conditions including cancer types (colorectal, lung, breast, prostate), rheumatoid arthritis, cardiovascular disease, and critically, prevention of congenital malformations and adverse pregnancy outcomes. The drug works by serving as a coenzyme in one-carbon transfer reactions essential for DNA synthesis, cell division, and normal fetal development.
As a legacy product approaching loss of exclusivity with minimal competitive pressure (score: 30), the brand team is likely focused on life-cycle extension and defensive positioning rather than growth expansion.
CLINICAL PHARMACOLOGY Folic acid acts on megaloblastic bone marrow to produce a normoblastic marrow. In man, an exogenous source of folate is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is the precursor of tetrahydrofolic acid, which is involved as…
Worked on FOLIC ACID at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Folic Acid Supplementation in Calcific Aortic Valve Disease
Serum Folic Acid Status, Genotyping MTHFR 677C-->T, Plasma Homocysteine, DNA Methylation of IGF2 Gene and Microbiota of the Children: Mother-Children Cohort Study
Folic Acid and Zinc Supplementation Trial (FAZST)
Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel
Folic Acid and Vitamin B12 in Young Indian Children
Folic acid roles are limited in number and heavily weighted toward defensive commercial strategy, market access, and lifecycle management. Career progression on this product is constrained by lack of blockbuster potential and R&D momentum, making it suitable for specialists in pricing, reimbursement, or foundational care rather than growth-oriented brand teams.